Clinical Trial: A Study to Investigate the Safety and Effectiveness of the Technolas(R) TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism

U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377474) titled 'A Study to Investigate the Safety and Effectiveness of the Technolas(R) TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism' on Jan. 22.

Brief Summary: This will be a multicenter, prospective, open label, non-randomized, single arm study evaluating the safety and effectiveness of the Technolas(R) TENEO 317 Model 2 (version 1.28 US software) Excimer Laser when used in LASIK surgery to treat myopia or myopic astigmatism. One or both eyes of a subject may be treated so long as both eyes meet all inclusion/exclusion requirements.

Study Start Date: April, 2026

Study Typ...